TAKEDA GAINS APPROVAL TO SELL BROPRESS AS HEART FAILURE TREATMENT IN JAPAN

The Ministry of Labor, Health and Welfare has approved Takeda Pharmaceutical Co Ltd's Bropress as a treatment for heart failure, Japan's largest drugmaker said in a statement. Bropress is the first antigotensin receptor blocker approved by the ministry here to treat heart failure, it said. Bropress, known as Candesartan in the US, was originally approved as a hypertension treatment.

Forbes (http://www.forbes.com/markets/feeds/afx/2005/10/11/afx2269404.html)